Abstract

Abstract Numerous studies have tested the association between TP53 mutations in ovarian cancer and prognosis but these have been consistently confounded by limitations in study design, methodology, and/or heterogeneity in the sample cohort. High‐grade serous (HGS) carcinoma is the most clinically important histological subtype of ovarian cancer. As these tumours may arise from the ovary, Fallopian tube or peritoneum, they are collectively referred to as high‐grade pelvic serous carcinoma (HGPSC). To identify the true prevalence of TP53 mutations in HGPSC, we sequenced exons 2–11 and intron–exon boundaries in tumour DNA from 145 patients. HGPSC cases were defined as having histological grade 2 or 3 and FIGO stage III or IV. Surprisingly, pathogenic TP53 mutations were identified in 96.7% ( n = 119/123) of HGPSC cases. Molecular and pathological review of mutation‐negative cases showed evidence of p53 dysfunction associated with copy number gain of MDM2 or MDM4 , or indicated the exclusion of samples as being low‐grade serous tumours or carcinoma of uncertain primary site. Overall, p53 dysfunction rate approached 100% of confirmed HGPSCs. No association between TP53 mutation and progression‐free or overall survival was found. From this first comprehensive mapping of TP53 mutation rate in a homogeneous group of HGPSC patients, we conclude that mutant TP53 is a driver mutation in the pathogenesis of HGPSC cancers. Because TP53 mutation is almost invariably present in HGPSC, it is not of substantial prognostic or predictive significance. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Keywords

OvarySerous fluidSerous carcinomaCarcinomaOvarian carcinomaMedicinePathologyBiologyOncologyInternal medicineCancerOvarian cancer

Affiliated Institutions

Related Publications

Publication Info

Year
2010
Type
article
Volume
221
Issue
1
Pages
49-56
Citations
794
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

794
OpenAlex

Cite This

Ahmed A. Ahmed, Dariush Etemadmoghadam, Jillian Temple et al. (2010). Driver mutations in <i>TP53</i> are ubiquitous in high grade serous carcinoma of the ovary. The Journal of Pathology , 221 (1) , 49-56. https://doi.org/10.1002/path.2696

Identifiers

DOI
10.1002/path.2696